Symbicort and health economics in a real life evaluation - SHARE - A randomised, open-label, parallel-group, multicentre study to assess the asthma-related health-care costs, in ordinary clinical practice during 12 months.
Phase of Trial: Phase III
Latest Information Update: 21 Jan 2011
At a glance
- Drugs Budesonide; Budesonide/formoterol; Formoterol; Terbutaline
- Indications Asthma
- Focus Therapeutic Use
- Acronyms SHARE
- Sponsors AstraZeneca
- 21 Jan 2011 Last checked against ClinicalTrials.gov record.
- 08 Oct 2008 Results presented at ERS in Oct 2008.
- 01 Oct 2008 Results published in Respiratory Medicine.